semaglutide drug maker Novo Nordisk's Ozempic® pill, the only FDA-approved oral peptide GLP-1 medication for adults with type 2 diabetes, soon to be available in the US Use of new diet drugs

Biermann recently led a study to try to develop a weaning protocol for these patients on smaller doses of GLP-1 drugs

One is that this study was observational, so it didnt definitively find that GLP-1s lowered the risk of severe migraine painit just found a link

Eye side effects of semaglutide Semaglutide is very effective for controlling blood sugar, but it can have a number of eye and systemic side effects

The Australian government banned the prescribing and dispensing of compounded semaglutide in October 2024 due to safety concerns, including reports of inconsistent potency

Rather than focusing only on the scale, maintenance plans are adjusted based on appetite control, energy levels, and day-to-day quality of life, helping results last well beyond the weight-loss phase